Sepsis

Everything

"R&D Trends: Sepsis" Published | PRLog
www.prlog.org | Jul 2, 2011
"R&D Trends: Sepsis" Published. New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research - PR11568433

Sepsis and Health Malpractice
www.goinglegal.com
Sepsis is a severe infection in a patient\'s bloodstream that can be contracted throughout surgical treatment or any invasive method where the blood i

Blocking Immune Cell Rush Behind Deadly Sepsis
www.dddmag.com
Researchers have found a way to block the ability of white blood cells to sprint toward the sites of infection when such speed worsens the damage done by sepsis.

Ozone Therapy and Hyperbaric Oxygen Treatment in Lung Injury in Septic Rats
www.medsci.org | Dec 16, 2011
<p>Various therapeutic protocols were used for the management of sepsis including hyperbaric oxygen (HBO) therapy. It has been shown that ozone therapy (OT) reduced inflammation in several entities and exhibits some similarity with HBO in regard to mechanisms of action. We designed a study to

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation
www.em-consulte.com
La Presse Médicale - Vol. 40 - N° 12P2 - p. e543-e560 - Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment - EM|consulte

Continuous StO2 monitoring in goal-directed shock and ICU resuscitation
www.ihe-online.com
Hospital devices Medical devices Products Articles Supplier E-Publications Ads Category Search Anaesthesiology / Analgesia Biomedical Engineering Cardiology Dermatology Emergency / Intensive care ENT/ Ophthalmology Furnishing/ Furniture Healthcare IT Infection Controls/ Sterilisation Medical

INFECTIONS IN NEONATAL INTENSIVE CARE Prevalence, Prevention and Antibiotic use Agnes van den...
nursing.nl
INFECTIONS IN NEONATAL INTENSIVE CARE Prevalence, Prevention and Antibiotic use Agnes van den Hoogen Infections In Neonatal Intensive Care Prevalence, Prevention and Antibiotic use Agnes van den Hoogen INFECTIONS IN NEONATAL INTENSIVE CARE Prevalence, Prevention and Antibiotic use September 2009

Eisai Revenues Set to Fall Off the 'Patent Cliff' as Sepsis Drug Hits Delay -- Seeking Alpha
seekingalpha.com | Mar 28, 2010
<strong><a href='http://www.epvantage.com/'>EP Vantage</a>submits:</strong><p><strong>Bigger is definitely not better for Eisai’s share price</strong></p><p><span>With patent expiry of its lead drug galloping towards it at high speed, the last thing that<a href="javascript:;"

News: Axis-Shield Acquires Rights to Develop Sepsis Diagnostic from Hansa Medical .
www.genengnews.com
Axis-Shield negotiated exclusive rights from Swedish company, Hansa Medical, to a heparin binding protein (HBP) assay for the development of a device to detect the onset of severe

TYKINERB
healthcare.zibb.com
Pharmaceutical Preparations For the Treatment of Cancer, [ Infectious Diseases, Pain, Inflammation, Sepsis, Alopecia and Obesity, and For the Treatment of Metabolic, Musculoskeletal, Cardiovascular, Cardiopulmonary, Genitourinary, Respiratory, Neurological, Gastrointestinal, Hormonal,